Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat + Atezolizumab + Bevacizumab in Advanced RCC
NCT03024437Phase 2Terminated
- Start
- Jun 2017
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in renal cell carcinoma (RCC). Started Jun 2017; status: terminated.
02
Drugs
entinostat
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT03024437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03024437.